Biogen Inc. (BIIB) stock
BIIBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3056% above fair value
$251.41+0.62 (+0.25%)
Close on Nov 18, 2026Market cap $37.16BP/E 107.4Yield –
Biogen market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Biogen's market cap was $37.52B on Nov 11, 2026, against $26.68B a year earlier. Over the last 5 years it ranged from $17.65B to $44.72B, with a median of $31.13B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $37.52B | +45.5% |
| 2025 | Dec 31, 2025 | $25.78B | +15.5% |
| 2024 | Dec 31, 2024 | $22.32B | -40.6% |
| 2023 | Dec 29, 2023 | $37.58B | -7.4% |
| 2022 | Dec 30, 2022 | $40.58B | +11.8% |
| 2021 | Dec 31, 2021 | $36.29B | -11.4% |
| 2020 | Dec 31, 2020 | $40.98B | -28.4% |
| 2019 | Dec 31, 2019 | $57.26B | -8.6% |
| 2018 | Dec 31, 2018 | $62.66B | -8.2% |
| 2017 | Dec 29, 2017 | $68.25B | +9.5% |
| 2016 | Dec 30, 2016 | $62.31B | -13.5% |
| 2015 | Dec 31, 2015 | $72.01B | -10.7% |
| 2014 | Dec 31, 2014 | $80.61B | +20.9% |
| 2013 | Dec 31, 2013 | $66.67B | +85.9% |
| 2012 | Dec 31, 2012 | $35.87B | +27.9% |
| 2011 | Dec 30, 2011 | $28.05B | +46.7% |
| 2010 | Dec 31, 2010 | $19.12B | +22.8% |
| 2009 | Dec 31, 2009 | $15.58B | – |
See a number that looks wrong?